BRCA2 and breast carcinoma: The decreased risk of breast cancer in SLE patients has been intriguing in light of mechanistic data suggesting that cell-penetrating dsDNA antibodies may have anti-cancer effects in cells with DNA repair defects, such as BRCA2-deficient human cancer cells [11].